Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Caspase 9 substrate.
Recombinant protein containing Treponema pallid...
Endogenous tachykinin peptide, involved in infl...
Flavonoid found in various plant sources; matri...
Thiazolidinedione; PPARα/γ agonist, mitoNEET ...
Natriuretic, vasodilatory peptide fragment; B1/...
Stem cell neurogenesis inducer.
Cyclosporin metabolite; weak calmodulin inhibit...
Macrolide; protein translation inhibitor, mamma...
Neuropeptide found in Locusta migratoria.
Triazole; 14α demethylase inhibitor.
Synthetic vasopressin derivative; V2R agonist.<...
PKC and PKD activator, carcinogen.
Form of vitamin C found in various plant and fo...
5-HT1A agonist, 5-HT1B partial agonist, 5-HT3A/...
GSK3 inhibitor.
Wortmannin analog; PI3K inhibitor.
Polyphenolic compound present in black tea.
Microtubule polymerization inhibitor.
Cannabinoid receptor 2 selective agonist.